Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 49, 70-79
- https://doi.org/10.1016/j.neuropharm.2005.05.018
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasiaNature Genetics, 2003
- Melanocyte destruction and repigmentation in vitiligo: A model for nerve cell damage and regrowthJournal of Biomedical Science, 2002
- Development of Cutaneous Amelanotic Melanoma in the Absence of a Functional TyrosinasePigment Cell Research, 2001
- Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytesJournal of Cellular Physiology, 2000
- Cell growth control by G protein-coupled receptors: from signal transduction to signal integrationOncogene, 1998
- Development of Heritable Melanoma in Transgenic MiceJournal of Investigative Dermatology, 1998
- Spotaneous Melanocytosis in Transgenic MiceJournal of Investigative Dermatology, 1996
- Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.The Journal of cell biology, 1989
- Ectopic Expression of the Serotonin 1c Receptor and the Triggering of Malignant TransformationScience, 1989
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983